Clinical Trial Update: Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Antistax (red vine leaf extract) for improving leg skin microcirculation in chronic venous insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency

Drugs mentioned

• Antistax (red vine leaf extract)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Insufficiency | Phase 2 | Status: COMPLETED